GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (OTCPK:ZLSCF) » Definitions » Tax Provision

ZLSCF (ZYUS Life Sciences) Tax Provision : $4.35 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Tax Provision?

ZYUS Life Sciences's tax provision for the three months ended in Sep. 2024 was $0.01 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was $4.35 Mil.


ZYUS Life Sciences Tax Provision Historical Data

The historical data trend for ZYUS Life Sciences's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Tax Provision Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Tax Provision
0.09 0.04 4.36

ZYUS Life Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.02 4.32 0.01 0.01 0.01

ZYUS Life Sciences Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ZYUS Life Sciences Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.

ZYUS Life Sciences Headlines

No Headlines